OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Ligand Pharmaceuticals/  US53220K5048  /

IEX
12/11/2024  20:43:19 Chg. -2.03 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
121.19USD -1.65% 2,205
Turnover: 266,629.68		 -Bid Size: - -Ask Size: - 2.29 bill.USD - 40.18

Assets

 2017
US GAAP
in mill. USD		 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD
Property and Equipment
  4.2120   5.3720   7.1850   14.4340   20.5110
Intangible Assets
  228.5840   219.7930   210.4480   595.3300   551.0400
Long-Term Investments
  6.4380   0.0000   -   -   -
Fixed Assets
  434   390.2630   371.2700   861.7260   832.8390
Inventories
  4.3730   7.1240   7.2960   26.4870   27.3260
Accounts Receivable
  25.5960   55.8500   30.3870   56.8470   85.4530
Cash and Cash Equivalents
  20.6200   117.1640   71.5430   47.6190   19.5220
Current Assets
  237.0210   870.5400   1,123.6450   500.5590   464.7510
Total Assets
  671.0210   1,260.8030   1,494.9150   1,362.2850   1,297.5900

 

Liabilities

 2017
US GAAP
in mill. USD		 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD
Accounts Payable
  2.2590   4.1830   2.4200   3.7840   8.4030
Long-term debt
  0.0000   609.8640   638.9590   442.2930   320.7170
Liabilities to Banks
  -   -   -   -   -
Provisions
  -   -   -   -   -
Liabilities
  271.2330   699.8890   727.6830   652.7600   476.4310
Share Capital
  .0210   .0210   .0170   .0160   .0170
Total Equity
  399.7880   560.9140   767.2320   709.5250   821.1590
Minority Interests
  0.0000   -   -   -   -
Total liabilities equity
  671.0210   1,260.8030   1,494.9150   1,362.2850   1,297.5900

 

Income Statement

 2017
US GAAP
in mill. USD		 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD
Revenues
  141.1020   251.4530   120.2820   186.4190   277.1330
Depreciation (total)
  -   -   -   -   -
Operating Result
  68.0760   163.7270   807.0760   25.8450   78.8950
Interest Income
  -11.4000   -48.2760   -7.3150   -19.3420   -18.7400
Income Before Taxes
  57.2310   173.3300   796.6390   -10.5380   47.2980
Income Taxes
  -44.6750   -30.0090   -167.3370   7.5530   9.8400
Minority Interests Profit
  0.0000   -   -   -   -
Net Income
  12.5560   143.3210   629.3020   -2.9850   57.1380

 

Per Share

 2017
US GAAP
in USD		 2018
US GAAP
in USD		 2019
US GAAP
in USD		 2020
US GAAP
in USD		 2021
US GAAP
in USD
Earnings per Share
  0.6000   6.7700   33.1300   -0.1800   3.4400
Dividend per Share
  -   -   -   -   -

 

Cash Flow

 2017
US GAAP
in mill. USD		 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD
Cash Flow from Operating Activities
  93.5680   194.0590   -29.3360   54.5860   78.7980
Cash Flow from Investing Activities
  -84.1770   -423.2690   466.9180   231.6480   30.5230
Cash Flow from Financing
  -7.5230   328.5850   -485.1720   -310.5450   -137.7610
Decrease / Increase in Cash
  1.8680   99.3750   -47.5900   -24.3110   -28.4400
Employees
  -   -   -   -   -